65 related articles for article (PubMed ID: 25341312)
1. Effects of two serotoninergic agents on the behavioral manifestations in rats.
Rusu G; Mitu F; Lupuşoru CE; Nechifor M; Lupuşoru RV; Mititelu-Tarţău L
Rev Med Chir Soc Med Nat Iasi; 2014; 118(3):854-9. PubMed ID: 25341312
[TBL] [Abstract][Full Text] [Related]
2. The effects of pregabalin on psycho-motor abilities and cognitive processes in mice.
Liliana MT; Lacramioara O; Catalina Elena L; Andra Sabina NV; Gabriela R; Gratiela P
Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):185-92. PubMed ID: 25970965
[TBL] [Abstract][Full Text] [Related]
3. Imidazoline receptor antagonists idazoxan and efaroxan enhance locomotor functions in rats.
Rusu G; Mititelu-Tartau L; Lupusoru CE; Lupusoru RV; Grigoraş I; Popa G; Nechifor M
Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):193-200. PubMed ID: 25970966
[TBL] [Abstract][Full Text] [Related]
4. Effects of some dopamine antagonists on spatial memory performance in rats--experimental research.
Rusu G; Popa G; Ochiuz L; Nechifor M; Tartau L
Rev Med Chir Soc Med Nat Iasi; 2014; 118(1):116-24. PubMed ID: 24741787
[TBL] [Abstract][Full Text] [Related]
5. Effects of some dopamine agents on modulation of memory processes performance in rats.
Rusu G; Nechifor M; Lupusoru CE; Tartau L
Rev Med Chir Soc Med Nat Iasi; 2013; 117(4):959-64. PubMed ID: 24502076
[TBL] [Abstract][Full Text] [Related]
6. Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats.
Wesołowska A; Nikiforuk A; Stachowicz K
Behav Pharmacol; 2007 Sep; 18(5-6):439-46. PubMed ID: 17762512
[TBL] [Abstract][Full Text] [Related]
7. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
Wesołowska A; Nikiforuk A
Neuropharmacology; 2007 Apr; 52(5):1274-83. PubMed ID: 17320917
[TBL] [Abstract][Full Text] [Related]
8. The anxiolytic-like effect of the selective 5-HT6 receptor antagonist SB-399885: the impact of benzodiazepine receptors.
Wesołowska A
Eur J Pharmacol; 2008 Feb; 580(3):355-60. PubMed ID: 18096153
[TBL] [Abstract][Full Text] [Related]
9. Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression.
Wesołowska A; Nikiforuk A; Stachowicz K; Tatarczyńska E
Neuropharmacology; 2006 Sep; 51(3):578-86. PubMed ID: 16828124
[TBL] [Abstract][Full Text] [Related]
10. 5HT(1A) and 5HT(1B) receptors of medial prefrontal cortex modulate anxiogenic-like behaviors in rats.
Solati J; Salari AA; Bakhtiari A
Neurosci Lett; 2011 Oct; 504(3):325-9. PubMed ID: 21982809
[TBL] [Abstract][Full Text] [Related]
11. The anxiolytic-like effect of 5-HT1B receptor ligands in rats: a possible mechanism of action.
Chojnacka-Wójcik E; Kłodzińska A; Tatarczyńska E
J Pharm Pharmacol; 2005 Feb; 57(2):253-7. PubMed ID: 15720791
[TBL] [Abstract][Full Text] [Related]
12. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
Yamaguchi T; Tsujimatsu A; Kumamoto H; Izumi T; Ohmura Y; Yoshida T; Yoshioka M
J Ethnopharmacol; 2012 Sep; 143(2):533-9. PubMed ID: 22819689
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity.
Dawson LA; Hughes ZA; Starr KR; Storey JD; Bettelini L; Bacchi F; Arban R; Poffe A; Melotto S; Hagan JJ; Price GW
Neuropharmacology; 2006 Jun; 50(8):975-83. PubMed ID: 16581092
[TBL] [Abstract][Full Text] [Related]
14. Microinjection of the 5-HT7 receptor antagonist SB-269970 into the rat brainstem and basal forebrain: site-dependent effects on REM sleep.
Monti JM; Leopoldo M; Jantos H; Lagos P
Pharmacol Biochem Behav; 2012 Aug; 102(2):373-80. PubMed ID: 22659581
[TBL] [Abstract][Full Text] [Related]
15. Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats.
Wesołowska A; Nikiforuk A; Stachowicz K
Eur J Pharmacol; 2006 Dec; 553(1-3):185-90. PubMed ID: 17097082
[TBL] [Abstract][Full Text] [Related]
16. Repeated blockade of 5-HT₇ receptors depresses glutamatergic transmission in the rat frontal cortex.
Tokarski K; Kusek M; Hess G
J Physiol Pharmacol; 2012 Apr; 63(2):173-7. PubMed ID: 22653904
[TBL] [Abstract][Full Text] [Related]
17. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent.
Stachowicz K; Chojnacka-Wójcik E; Kłak K; Pilc A
Neuropharmacology; 2007 Feb; 52(2):306-12. PubMed ID: 17020774
[TBL] [Abstract][Full Text] [Related]
18. In vivo biocompatibility evaluation of some Bidens tripartita extracts in rats.
Sandu RB; Tarţău L; Miron A; Zagnat M; Ghiciuc CM; Lupuşoru CE
Rev Med Chir Soc Med Nat Iasi; 2013; 117(3):795-800. PubMed ID: 24502053
[TBL] [Abstract][Full Text] [Related]
19. Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents.
Bonaventure P; Kelly L; Aluisio L; Shelton J; Lord B; Galici R; Miller K; Atack J; Lovenberg TW; Dugovic C
J Pharmacol Exp Ther; 2007 May; 321(2):690-8. PubMed ID: 17314195
[TBL] [Abstract][Full Text] [Related]
20. 5-HT(1A) and 5-HT(7) receptors differently modulate AMPA receptor-mediated hippocampal synaptic transmission.
Costa L; Trovato C; Musumeci SA; Catania MV; Ciranna L
Hippocampus; 2012 Apr; 22(4):790-801. PubMed ID: 21538661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
